These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2830474)

  • 1. Sequence homology between encephalomyocarditis virus protein VPI and histidyl-tRNA synthetase supports a hypothesis of molecular mimicry in polymyositis.
    Walker EJ; Jeffrey PD
    Med Hypotheses; 1988 Jan; 25(1):21-5. PubMed ID: 2830474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymyositis and molecular mimicry, a mechanism of autoimmunity.
    Walker EJ; Jeffrey PD
    Lancet; 1986 Sep; 2(8507):605-7. PubMed ID: 2427902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitope mapping of the cloned human autoantigen, histidyl-tRNA synthetase. Analysis of the myositis-associated anti-Jo-1 autoimmune response.
    Ramsden DA; Chen J; Miller FW; Misener V; Bernstein RM; Siminovitch KA; Tsui FW
    J Immunol; 1989 Oct; 143(7):2267-72. PubMed ID: 2476503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranuclear location of the myositis-specific Jo-1 antigen: hopping histidyl-tRNA synthetase?
    Dang CV
    Arthritis Rheum; 1985 Jul; 28(7):839-40. PubMed ID: 2409986
    [No Abstract]   [Full Text] [Related]  

  • 5. Purification of mammalian histidyl-tRNA synthetase and its interaction with myositis-specific anti-Jo-1 antibodies.
    Fahoum SK; Yang DC
    Biochemistry; 1987 Sep; 26(18):5871-7. PubMed ID: 3499936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification of bovine liver histidyl-tRNA synthetase, the Jo-1 antigen of polymyositis: size of the whole enzyme and its characteristic proteolytic fragments.
    Walker EJ; Jeffrey PD
    Biol Chem Hoppe Seyler; 1987 May; 368(5):531-7. PubMed ID: 3620106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histidyl-tRNA synthetase, the myositis Jo-1 antigen, is cytoplasmic and unassociated with the cytoskeletal framework.
    Dang CV; LaDuca FM; Bell WR
    Exp Cell Res; 1986 May; 164(1):261-6. PubMed ID: 3956597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myositis autoantibody inhibits histidyl-tRNA synthetase: a model for autoimmunity.
    Mathews MB; Bernstein RM
    Nature; 1983 Jul 14-20; 304(5922):177-9. PubMed ID: 6866113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rat liver histidyl-tRNA synthetase. Purification and inhibition by the myositis-specific anti-Jo-1 autoantibody.
    Yang DC; Dang CV; Arnett FC
    Biochem Biophys Res Commun; 1984 Apr; 120(1):15-21. PubMed ID: 6712685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A motif in human histidyl-tRNA synthetase which is shared among several aminoacyl-tRNA synthetases is a coiled-coil that is essential for enzymatic activity and contains the major autoantigenic epitope.
    Raben N; Nichols R; Dohlman J; McPhie P; Sridhar V; Hyde C; Leff R; Plotz P
    J Biol Chem; 1994 Sep; 269(39):24277-83. PubMed ID: 7523371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved detection of anti-Jo-1 antibody, a marker for myositis, using purified histidyl-tRNA synthetase.
    Walker EJ; Tymms KE; Webb J; Jeffrey PD
    J Immunol Methods; 1987 Feb; 96(2):149-56. PubMed ID: 3100649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-D region genes associated with autoantibody responses to histidyl-transfer RNA synthetase (Jo-1) and other translation-related factors in myositis.
    Goldstein R; Duvic M; Targoff IN; Reichlin M; McMenemy AM; Reveille JD; Warner NB; Pollack MS; Arnett FC
    Arthritis Rheum; 1990 Aug; 33(8):1240-8. PubMed ID: 1975177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies.
    Dugar M; Cox S; Limaye V; Blumbergs P; Roberts-Thomson PJ
    Intern Med J; 2011 Sep; 41(9):674-9. PubMed ID: 20059602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies to aminoacyl-transfer RNA synthetases for isoleucine and glycine. Two additional synthetases are antigenic in myositis.
    Targoff IN
    J Immunol; 1990 Mar; 144(5):1737-43. PubMed ID: 2307838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of antibody to Jo-1 by ELISA and comparison to enzyme inhibitory activity.
    Targoff IN; Reichlin M
    J Immunol; 1987 May; 138(9):2874-82. PubMed ID: 3553328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with non-Jo-1 anti-RNA-synthetase autoantibodies have worse survival than Jo-1 positive patients.
    Hervier B; Devilliers H; Benveniste O
    Ann Rheum Dis; 2013 Jul; 72(7):e18. PubMed ID: 23644669
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-Jo-1 autoantibodies and the immunopathogenesis of autoimmune myositis.
    Tsui FW; Siminovitch KA
    Int Rev Immunol; 1991; 7(3):225-35. PubMed ID: 1721933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation and partial stabilization of human histidyl-tRNA synthetase by hemoglobin.
    Biswas T; Miller FW; Plotz PH
    FEBS Lett; 1988 Feb; 229(1):203-5. PubMed ID: 3345836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells.
    Howard OM; Dong HF; Yang D; Raben N; Nagaraju K; Rosen A; Casciola-Rosen L; Härtlein M; Kron M; Yang D; Yiadom K; Dwivedi S; Plotz PH; Oppenheim JJ
    J Exp Med; 2002 Sep; 196(6):781-91. PubMed ID: 12235211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical manifestations in patients with antibody to PL-12 antigen (alanyl-tRNA synthetase).
    Targoff IN; Arnett FC
    Am J Med; 1990 Mar; 88(3):241-51. PubMed ID: 2178410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.